Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus

  • Jian-mei ZOU ,
  • Li-jun WU ,
  • Cai-nan LUO ,
  • Ya-mei SHI ,
  • Xue WU
Expand
  • Department of Rheumatology and Immunology, Xinjiang Uygur Autonomous Region People’s Hospital, Urumqi 830001, China

Received date: 2019-10-23

  Online published: 2021-10-11

Abstract

Objective: To investigate the application value of serum 25-hydroxy vitamin D [25(OH)D] in systemic lupus erythematosus (SLE). Methods: Data of 158 patients with SLE in Department of Rheumatology and Immunology in the People’s Hospital of Xinjiang Uygur Autonomous Region from July 2016 to July 2019. All the SLE patients were divided into two groups by SLE scores of the disease activity index (SLEADI): 59 cases of active group (SLEADI>4), 99 cases of non-active group (SLEDAI ≤4). Fifty healthy people were selected as healthy control group. The patients’ general information and their laboratory data including serum 25(OH)D levels were collected. Statistical methods used were t-test, Spearman’s correalation analysis and Logistic regression analysis. Results: (1) A total of 208 cases were included in this study. The level of 25(OH)D in SLE group [10.4(5.6,15.8) μg/L] was significantly lower than that in healthy control group [25.5(22.8,32.3) μg/L, P<0.01]. 25(OH)D level in active SLE patients [6.2(3.7,13.8) μg/L] was significantly lower than that in remission SLE patients [12.3(7.2,16.7) μg/L, P<0.01]. The serum 25(OH)D level in lupus nephritis [6.7 (4.4, 12.9) μg/L] was significantly lower than that in SLE without renal involvement [13.3 (7.4, 18.7) μg/L, P<0.01]. (2) A significant negative correlation was demonstrated between the serum level of 25(OH)D and SLEDAI (r=-0.35,P<0.01), and the 24h urinary protein excretion (r=-0.39, P<0.01).Positive correlation was demonstrated between the serum level of 25(OH)D and C3 that decreased (r=0.249, P<0.05). (3) Univariate analysis showed anti- dsDNA antibodies(ds-DNA), anti-Sm antibodies(Sm), IgG, C3, C4, erythrocyte sedimentation rate (ESR), 24h urinary protein quantification(24h-pro) and 25(OH)D were associated with disease activity in the SLE patients; Multivariate Logistic regression analysis showed that 25(OH)D was associated with the disease activity of the lupus patients. Conclusion: The decrease of vitamin D level is related to the disease activity of SLE patients, and may be related to lupus nephritis, which plays an important role in the occurrence and development of SLE.

Cite this article

Jian-mei ZOU , Li-jun WU , Cai-nan LUO , Ya-mei SHI , Xue WU . Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus[J]. Journal of Peking University(Health Sciences), 2021 , 53(5) : 938 -941 . DOI: 10.19723/j.issn.1671-167X.2021.05.021

References

[1] Cutolo M, Otsa K. Review: Vitamin D, immunity and lupus [J]. Lupus, 2008, 17(1):6-10.
[2] Kamen DL. Vitamin D in lupus-new kid on the block? [J]. Bull NYU Hosp Jt Dis, 2010, 68(3):218-222.
[3] Ritterhouse LL, Crowe SR, Niewold TB, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus [J]. Ann Rheum Dis, 2011, 70(9):1569-1574.
[4] Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? [J]. Ann Rheum Dis, 2010, 69(6):1155-1157.
[5] Yeap SS, Othman AZ, Zain AA, et al. Vitamin D levels: Its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids [J]. Int J Rheum Dis, 2012, 15(1):17-24
[6] Souto M, Coelho A, Guo C, et al. Vitamin D insufficiency in Brazilian patients with SLE: Prevalence, associated factors, and relationship with activity [J]. Lupus, 2011, 20(10):1019-1026.
[7] De Souza VA, Bastos MG, Fernandes NM, et al. Association of hypovitaminosis D with systemic lupus erythematosus and inflammation [J]. Bras Nefrol, 2014, 36(4):430-436.
[8] Leventis P, Patel S. Clinical aspects of vitamin D in the management of rheumatoid arthritis [J]. Rheumatology (Oxford), 2008, 47(11):1617-1621.
[9] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997, 40(9):1725-1734.
[10] Ding Y, Liao W, He XJ, et al. Effects of 1,25(OH)2 D3 and vitamin D receptor on peripheral CD4+/CD8+double-positive T lymphocytes in a mouse model of systemic lupus erythematosus [J]. J Cell Mol Med, 2017, 21(5):975-985.
[11] Mok CC. Vitamin D and systemic lupus erythematosus: an update [J]. Expert Rev Clin Immunol, 2013, 9(5):453-463.
[12] 张竞, 罗静, 王静, 等. 血清25(OH)D水平与初诊系统性红斑狼疮疾病活动度的相关性研究 [J]. 中华风湿病学杂志, 2019, 23(1):36-41.
[13] 方慧玲, 禹松林, 韩建华, 等. 中国北方健康人群血清 25羟维生素D3和25羟维生素D2水平 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2014, 7(3):199-205.
[14] Cashman KD, Dowling KG. Vitamin D deficiency in Europe: Pandemic? [J]. Am J Clin Nutr, 2016, 103(4):1033-1044.
[15] 张永锋, 郑毅. 初发系统性红斑狼疮患者血清25-羟-维生素D和维生素D抗体水平变化及意义 [J]. 中华风湿病学杂志, 2012, 16(10):661-664.
[16] 卢勤燕, 蔡小燕, 林小军, 等. 系统性红斑狼疮患者外周血维生素D水平及其临床意义 [J]. 实用医学杂志, 2015, 31(7):1123-1125.
[17] 洪琼. 25羟基维生素D与类风湿关节炎及系统性红斑狼疮的相关性研究 [D]. 安徽, 安徽医科大学, 2013: 1-108.
[18] Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synjournal on the incidence of autoimmune disease [J]. Nat Clin Pract Rheumatol, 2009, 5(2):99-105.
[19] 陈铭聿, 孙彬, 张波, 等. 狼疮肾炎患者血维生素D3水平与疾病活动度的相关性研究 [J]. 中华肾脏病杂志, 2015, 31(2):881-886.
Outlines

/